Cybin (HELP) Shares Outstanding (2020 - 2026)
Cybin (HELP) posted quarterly Shares Outstanding (Entity) of $34.8 million for Q1 2026, up 1547.62% year-on-year from $2.1 million in Q1 2025, and up 859.29% on a QoQ basis from $3.6 million in Q3 2025.
Cybin (HELP) Shares Outstanding (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Shares Outstanding (Entity) for 7 consecutive years, with $34.8 million the latest figure, recorded in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 1547.62% year-over-year to $34.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.8 million (up 1547.62% YoY) and the FY2026 annual result came in at $34.8 million, up 1496.22% from the prior year.
- Shares Outstanding (Entity) improved to $34.8 million in Q1 2026 per HELP's latest filing, from $3.6 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for HELP reached as high as $34.8 million in Q1 2026 and fell as low as $546976.8 in Q3 2022.
- A 5-year average of $3.5 million and a median of $980221.0 in 2022 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 2.08% — and 2026, when it soared 1547.62%.
- Year by year, Shares Outstanding (Entity) stood at $548940.2 in 2022, then soared by 76.14% to $966879.4 in 2023, then surged by 121.95% to $2.1 million in 2024, then surged by 69.06% to $3.6 million in 2025, then jumped by 859.29% to $34.8 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $34.8 million, $3.6 million, and $2.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 34.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.80 Mn |
| Dec 31, 2025 | 42.52 Mn |
| Sep 30, 2025 | 24.21 Mn |
| Jun 30, 2025 | 22.40 Mn |
| Mar 31, 2025 | 20.22 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Dec 31, 2023 | 8.78 Mn |
| Sep 30, 2023 | 6.17 Mn |
| Jun 30, 2023 | 5.43 Mn |
| Feb 28, 2023 | 8.46 Mn |
| Dec 31, 2022 | 4.97 Mn |
| Sep 30, 2022 | 4.76 Mn |
| May 31, 2022 | 8.42 Mn |
| Mar 31, 2022 | 4.40 Mn |
| Feb 28, 2022 | 4.52 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.36 Mn |